Share :

partage facebook
partage twitter
partage linkedin

Studies seem to confirm that there are fewer individuals of blood group O in Covid-19 patients, suggesting a protective effect of O blood group against the virus. Similarly, among severely affected individuals, A and AB groups are more likely to have pulmonary and renal failure.

Our expert speaker, Jacques Le Pendu, Research Director at Inserm in Nantes, will offer a scientific approach of the relationship between Covid-19 and blood groups during this webinar organized by DIAGAST.

Register for the next webinar
on DIAGAST Live!

Registrations open on September 14, 2021

This webinar provides an overview of the relationship between ABO blood types and Covid-19 and will attempt to answer questions such as:

  • Is there a link between blood groups and the risk of infection or disease severity?
  • If so, what mechanisms could be involved?
  • And what could be potentially conclude in terms of controlling the epidemic?

Join us for this live intervention and ask your questions to our expert:

Tuesday, October 5, 2021, at 11:00 am for the session in English and at 2:00 pm for the session in French.

Discover our expert speaker, Jacques Le Pendu

Jacques Le Pendu’s main research projects focus on the relationships between terminal glycosylations, such as histo-blood group antigens, and pathogen susceptibility. He has authored or co-authored over 180 publications in peer-reviewed issues, 10 book chapters and 3 patents.  In particular, he supervised the analysis of about 40 studies on the correlation between blood type and risk of infection with Covid-19. This analysis published in “Viruses” will be commented on, and an update will be provided during his presentation.

Do you know DIAGAST Live?

Before and after the live webinar, you will be able to navigate freely through original content on DIAGAST Live: product demonstrations, video interviews… and a live chat with our teams. We are here for you!